Peer Review History
| Original SubmissionMarch 21, 2022 |
|---|
|
PONE-D-22-08369Predicting the diagnosis and prognosis of necrotizing enterocolitis using a novel feature selection frameworkPLOS ONE Dear Dr. Li, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.Please submit your revised manuscript by Jul 21 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vijayalakshmi Kakulapati, Ph.D Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. Please provide additional details regarding participant consent. In the ethics statement in the Methods and online submission information, please ensure that you have specified (1) whether consent was informed and (2) what type you obtained (for instance, written or verbal, and if verbal, how it was documented and witnessed). If your study included minors, state whether you obtained consent from parents or guardians. If the need for consent was waived by the ethics committee, please include this information. If you are reporting a retrospective study of medical records or archived samples, please ensure that you have discussed whether all data were fully anonymized before you accessed them and/or whether the IRB or ethics committee waived the requirement for informed consent. If patients provided informed written consent to have data from their medical records used in research, please include this information. 4. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager. Please see the following video for instructions on linking an ORCID iD to your Editorial Manager account: https://www.youtube.com/watch?v=_xcclfuvtxQ 5. Thank you for stating the following financial disclosure: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” At this time, please address the following queries: a) Please clarify the sources of funding (financial or material support) for your study. List the grants or organizations that supported your study, including funding received from your institution. b) State what role the funders took in the study. If the funders had no role in your study, please state: “The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.” c) If any authors received a salary from any of your funders, please state which authors and which funders. d) If you did not receive any funding for this study, please state: “The authors received no specific funding for this work.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: I Don't Know Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: 1. Line 1: Based on the content of the work, I will rather suggest the author coin the topic in line with the modified algorithm RQBSO. Aside this, the work will expose the novelty not the topic. However, I suggest something like “Framework for feature selection of predicting the diagnosis and prognosis of nectrotizing enterocolitis” 2. Line 23-26: list some potential influencing factors ignored 3. Line 29—31: What is RQBSO? NEC? And does linear support vector machine translate to SVM? 4. Line 47: I’m not aware this type of citation style 5. Line 54: Check the sentence especially the use of the word “mine” 6. Line 74: Take abbreviation outside the table as note 7. Line 82: Second or secondly 8. Line 84: kindly justify why the need to improve prediction requires inclusion of more features 9. Line 91-94: consider review into smaller sentences 10. Line 112: This suggest the main focus of this work, the abbreviations need to be check especially how line 113-114 translate to RQBSO 11. Line 127: from this stage the heading and heading numbering are defective. Check the heading style and heading numbering of the journal. Specifically, heading line 127 and line 177 should go together and each description of information in it must flow and justified 12. Line 149: The patient characteristics should have gone with line 128, Patient and data sets 13. Line 155-156. This covers about four pages of data. These data shouldn’t have come under material used or patient characteristics rather data presentation or during analysis. If it should be here kindly justify 14. Line 178-179: the proposed method include three steps-two steps mentioned and the heading that follows are more than three. Coordinate and arrange your materials to follow the proposed steps 15. Line 182 onward contained mathematical expressions which the character and formatting impair the quality of information in the equation. For example, in line 188, the multiplication sign is not far from the other x’s define in the equation 16. Line 194: Reconcile eqt2 because there will be a problem if it is substituted into eqt1 17. Line 202: check eqt3 18. Line 211: in this work we use the RQBSO algorithm……., if RQBSO is the main focus, it must have been describe before this place 19. Line 230: delete Eq.(5) 20. Line 223-241: You need to utilize software that can improve your mathematical writings to make sense, this applies to all equations in the work 21. Line 250, 268 and 298: headings 22. Line 312: the entirty of these section should have been devoted to development and justification of RQBSO where the figure will now be pictorial representation of the proposed method. As it stand now, this section is the pillar of the work which needs to be strengthened 23. Lines 314, 319, 329, 336, 341, 347 should go to introduction or still reeiw of relevant tools but not where the main work is been discussed. It can only be mentioned to justify its use 24. Line 353-356: deliberate action is needed to cite and justify these equations 25. Line 358: Evaluation cannot be done under the heading Result and Discussion. Is either the heading or content is faulty 26. Line 357 and line 441: reconcile 27. Line 470: Here, we can simply be ……’’In this work, a novel………’’ 28. Line 478: the word … most… there must be specific by mentioning the existing …… General Comment My adventure of going through this work suggest to me that the author has lots of materials to be presented to justify publication. Unfortunately, the materials were not well organized and presented. The language of communication is good but research writing and presentation is lack which hindere the flow of communication. Aside this 1. Style and formatting 2. Heading and heading numbering 3. Citations referencing style (I don’t know if this is the journal style) 4. Probably due to submission, I suggest all part are put together before released for reviewing Reviewer #2: The manuscript has very well and enough introduction, all the analysis and calculations are made in good manner. The figures are in a good resolution and all the references are put in order of date. The manuscript has got accepted from my side. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: MKA Abdulrahman Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Framework for feature selection of predicting the diagnosis and prognosis of necrotizing enterocolitis PONE-D-22-08369R1 Dear Dr. Li, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Vijayalakshmi Kakulapati, Ph.D Academic Editor PLOS ONE |
| Formally Accepted |
|
PONE-D-22-08369R1 Framework for feature selection of predicting the diagnosis and prognosis of necrotizing enterocolitis Dear Dr. Li: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Vijayalakshmi Kakulapati Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .